“Trump announced the next in a long line of vanity projects: TrumpRX, a forthcoming, federally branded website where Pfizer sells steeply discounted drugs in exchange for a three-year exemption from his proposed 100 percent tariffs on imported pharmaceuticals. Imagine a strip mall furniture store with a permanent, flashy 70-percent-off sale, masking the fact that prices were inflated in the first place. TrumpRx, slated to launch in early 2026, is no different—a government-run platform that promises savings while hiding costs.
…
TrumpRx isn’t healthcare reform or even a program in any real sense. It’s a carve-out for one company. Under the agreement, Pfizer will list a large share of its primary care and select specialty drugs at deep discounts on a federal site that redirects patients to Pfizer’s direct-to-consumer checkout.
…
The savings are shaky because that money has to come from somewhere. Part of it, certainly, is just the market advantage of being exempted from a 100 percent tax that all your competitors are forced to pay. Any savings beyond that will be carved out of something else—less research, higher prices on other drugs, or hidden costs buried elsewhere in the system.
And for most people, the ‘discounts’ aren’t really discounts. Roughly 90 percent of Americans are insured, and their co-pays are almost always cheaper than TrumpRx’s cash prices. Medicaid patients already get the steepest rebates—more than 60 percent off by law—so TrumpRx adds little there. That leaves the approximately 27 million uninsured Americans.
But even for the uninsured, the math falls apart: A $6,000 arthritis drug at “half price” is still $3,000 in cash, a stretch on any budget. Eucrisa at $162 on TrumpRx beats few insurance copays. And $499/month for Wegovy (semaglutide) on TrumpRx compares poorly to the $25 many insured patients now pay. And all of this bypasses the way Americans actually get prescriptions. CVS, Walgreens, and the rest are cut out entirely, replaced by a federally branded coupon pop-up that punts you to a manufacturer’s checkout page. TrumpRx looks like a deal, but in practice, it helps almost no one.”
https://reason.com/2025/10/02/trumprx-is-obamacare-in-trumps-handwriting